# The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.

> **NCT02987907** · PHASE3 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 220 (estimated)

## Conditions studied

- HepatoCellular Carcinoma

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT02987907
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2019-07
- **Final completion:** 2019-08
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2016-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02987907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02987907, "The Impact on Therapeutic Effect and Tolerance of Treatment for Patients With Hepatocellular Carcinoma in Transcatheter Arterial Chemoembolization (TACE) of Dexamethasone Application: A Random, Double-blind, Controlled, Clinical Trial.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02987907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*